摘要
1文献来源Cristofanilli M,Turner NC,Bondarenko I,et al.Fulvestrant plus Palbociclib versus Fulvestrant plus placebo for treatment of hormone-receptorpositive,HER2-negative metastatic breast cancer that progressed on previous endocrine therapy（PALOMA-3）：Final analysis of the multicentre,double-blind,phase 3 randomised controlled trial[J].Lancet Oncol,2016,17（4）：425-439.
出处
《循证医学》
CSCD
2016年第3期152-154,共3页
The Journal of Evidence-Based Medicine
